Asia’s First Real-World ctDNA-MRD Study Strengthens Evidence for Cost-Effective Cancer Monitoring
A landmark study recently published in March 2025 by JCO Oncology Advances, demonstrates the potential of K-TRACKTM in monitoring treatment response and assessing recurrence risk among 623 Solid-Tumor Patients of six cancer types (lung, colorectal, breast, gastric, liver, or ovarian cancer).(1) SINGAPORE, April 19, 2025 /PRNewswire/ -- Gene Solutions, a biotechnology company dedicated to advancing precision oncology in Asia,...
Innovation and Collaboration: Advancing China’s Blood Purification Industry
LIUYANG, China, April 19, 2025 /PRNewswire/ -- On April 19, 2025, the Blood Purification Professional Committee (BPPC) of the China Medical Device Industry Association (CMDIA) gathered in Liuyang, Hunan, for its annual conference, themed "Synergy and Endless Innovation." This pivotal event united regulatory leaders, academic experts, and pioneering medical device companies to propel advancements in blood purification technologies, integral to...
Interpret Corporate Vitality Through Running, Baijiayun Spring Health Run Event successfully held
BEIJING, April 19, 2025 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced that it held a Spring Health Run event with the theme of "Chasing Light in the Green Fields • Setting Sail towards Health" at its Beijing office on April 17th. The competition was divided into two...
Declaration on longevity and precision medicine launched at Abu Dhabi Global Health Week
Establishing actionable frameworks to advance precision medicine and longevity science The declaration highlights the impact longevity and precision medicine can have on supporting healthy communities, and engages leaders to work towards actionable solutions, drive consensus among global peers, and invest in long-term solutions It brings together leading healthcare and academic institutions...
Asieris Pharmaceuticals Releases 2024 Annual Report, with Revenue Exceeding RMB 200M in 1st Year of Commercialization and Innovative Portfolio Accelerating Toward Launch
SHANGHAI, April 18, 2025 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2024 Annual Report, highlighting a bold and determined journey forward. With a specialty pharma strategy and operational efficiency, the company exceeded its commercialization targets and advanced its innovative products — APL-1702 and APL-1706 (Hexvix®) — toward market launch. R&D efforts also gained strong momentum, with 12 products in...
Akeso’s Ebdarokimab ( IL – 12/IL – 23 Dual – Targeted Monoclonal Antibody) Approved in China for Moderate – to – Severe Plaque Psoriasis
HONG KONG, April 18, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal antibody developed by the company, has received marketing approval from the National Medical Products Administration (NMPA) for the treatment of moderate-to-severe plaque psoriasis in adult patients. Ebdarokimab is the company's first Class 1 new drug...
WuXi Biologics Completes First Commercial PPQ Campaign at 15,000L Production Line in Hangzhou Site
- The campaign marks the successful commercial-scale PPQ completion of Asia's first 3 X 5,000L single-use bioreactors- Proprietary process innovation reduces protein cost by nearly 70% while boosting yield 20%- As the company's largest operational single-use bioreactor to date, the system triples total site capacity to 23,000L, enabling flexible scale-up solutions HANGZHOU, China, April 18, 2025 /PRNewswire/ -- WuXi...
VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model
SHANGHAI and BOSTON, April 18, 2025 /PRNewswire/ -- VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specific antibodies and antibody-drug conjugate (ADC), today announced its second out-licensing agreement of a first-in-class (FIC) asset to Ollin Biosciences, Inc. ("Ollin"), granting Ollin an exclusive license to develop, manufacture and...
VISTA Eye Specialist and Tzu Chi Malaysia Continue Their Mission to Restore Sight for Underprivileged
PETALING JAYA, Malaysia, April 18, 2025 /PRNewswire/ -- In a heartfelt continuation of their mission to serve the underserved, VISTA Eye Specialist (VISTA) and Tzu Chi Malaysia (Tzu Chi) have once again partnered to restore sight for the underprivileged through their second 100 Cataract Surgery Program (Program). VISTA, Tzu Chi, and UCSI volunteers at Tzu...
Rhino Rescue Launches New Outdoor Product Lineup to Enhance Safety for Adventurers
LOS ANGELES, April 17, 2025 /PRNewswire/ -- Rhino Rescue, a global leader in emergency preparedness solutions, recently launched its latest innovations: the Rhino Rescue Mini First Aid Kit, a compact yet comprehensive emergency kit specifically designed for high-activity outdoors, the Home First Aid Kit specifically designed for home and office use, and the Outdoor Camping First Aid Kit designed for...
